| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $687.4M | +1.5% |
| Gross Profit | $198.2M | +0.5% |
| R&D Expense | $2.0M | -20.8% |
| SG&A Expense | $166.6M | +3.3% |
| Operating Income | $19.8M | +9.0% |
| Interest Expense | $10.5M | -3.5% |
| Pre-tax Income | $9.3M | +27.5% |
| Income Tax | $2.7M | -19.9% |
| Net Income | $6.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | -15.0% |
| Accounts Receivable | $123.7M | +12.9% |
| Inventory | $13.6M | +6.9% |
| Current Assets | $167.9M | +4.1% |
| Total Assets | $534.9M | -4.9% |
| Current Liabilities | $103.7M | -14.6% |
| Long-term Debt | $191.3M | -5.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.4M | -37.5% |
| Capital Expenditures | $12.6M | -30.7% |
| Investing Cash Flow | -$12.2M | +34.0% |
| Financing Cash Flow | -$16.3M | +29.8% |
| Free Cash Flow | $13.8M | -42.7% |
| +68.4% |
| EPS (Basic) | $0.22 | +69.2% |
| EPS (Diluted) | $0.21 | +61.5% |
| Total Liabilities |
| $336.2M |
| -7.0% |
| Stockholders' Equity | $198.4M | -1.1% |